Sean A Fletcher

41PUBLICATIONS
265CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPeripheral nervous systemRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 17, 2026
Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration-Resistant Prostate Cancer.

|Jul 16, 2026
Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study.

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Feb 19, 2026
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

Pageof 7

Frequent Collaborators

12 joint publications

Emmanuel S Antonarakis

9 joint publications

Catherine H Marshall

9 joint publications

Samuel R Denmeade

8 joint publications

Mark Markowski